Solanbridge Group, Inc. is a development-stage company. The Company is a holding company. The Company is looking to expand into the medical marijuana industry by developing a commercial grower's license in the Province of Nova Scotia, Canada and developing cannbidiol (CBD) infused products in Nevada, California and Colorado. The Company focuses on providing a product that will help physicians and patients in managing health, and it will be available only to Canadians holding a legal license to possess medical marijuana. Solanbridge Group Nova Scotia, Inc. is a subsidiary of the Company.